EAM
FOLD

EverPoint Asset Management’s Amicus Therapeutics FOLD Stock Holding History

EverPoint Asset Management’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$1.04M Buy
+210,272
New +$1.46M 0.02% 367

Other funds holding FOLD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

EverPoint Asset Management's FOLD Position: Q4 2016 in Review

EverPoint Asset Management opened a new position in Amicus Therapeutics (FOLD) in Q4 2016: 210,272 shares worth $1.04M. The stake represents 0.02% of the portfolio and ranks #367 among its holdings.

135 funds tracked by Wall St. Rank hold FOLD as of Q4 2016.

  • EverPoint Asset Management held 210,272 shares of Amicus Therapeutics worth $1.04M as of Q4 2016.
  • Amicus Therapeutics was a new EverPoint Asset Management position in Q4 2016.
  • Amicus Therapeutics made up 0.02% of EverPoint Asset Management's portfolio in Q4 2016, its #367 holding.
  • 135 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q4 2016.

Based on EverPoint Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.